The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
B7-H3 expression by immunohistochemistry as a negative prognostic biomarker in colorectal carcinoma (CRC) in a racially diverse population.
 
Meghan Kaumaya
No Relationships to Disclose
 
Wei Zhang
No Relationships to Disclose
 
Kevin Kuan
No Relationships to Disclose
 
Sorab Gupta
No Relationships to Disclose
 
Shaomin Hu
No Relationships to Disclose
 
Devika Rao
Stock and Other Ownership Interests - Baxter (I)
 
Kim Ohaegbulam
No Relationships to Disclose
 
Richard Hwang
No Relationships to Disclose
 
Qiang Liu
No Relationships to Disclose
 
Xingxing Zang
No Relationships to Disclose
 
Sanjay Goel
Research Funding - Oncolytics (Inst)
Patents, Royalties, Other Intellectual Property - I have a patent with a co-inventor, John Mariadason, Ph.D, entitled "Method Of Determining The Sensitivity Of Cancer Cells To EGFR Inhibitors Including Cetuximab, Panitumumab And Erlotinib.", Patent No. 20090258364
 
Radhashree Maitra
No Relationships to Disclose